Benign neoplasm: Sigmoid colon

CD2_BENIGN_SIGMOID_COLON

sigmoid neoplasm: Tumors or cancer of the sigmoid colon.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12.5& Hospital discharge: ICD-8 — 21136 Cause of death: ICD-10 — D12.5& Cause of death: ICD-8 — 21136 2 out of 7 registries used, show all original rules.	7270
4. Check minimum number of events None	7270
5. Include endpoints None	7270
6. Filter based on genotype QC (FinnGen only)	7270

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D12
Name in latin: Neoplasma benignum coli sigmoidei

NAME	CD2_BENIGN_SIGMOID_COLON
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D125
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	21136
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D125
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	21136
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Sigmoid colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Sigmoid colon

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37730	18380	19154
Only index persons	35117	17393	17724
Unadjusted period prevalence (%)
Whole population	0.53	0.53	0.54
Only index persons	0.66	0.64	0.68
Median age at first event (years)
Whole population	66.24	66.47	66.02
Only index persons	65.89	66.07	65.71

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7270	3486	3784
Unadjusted period prevalence (%)	1.44	1.19	1.67
Median age at first event (years)	65.76	64.63	66.80

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6330: Matched controls
63298

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

323.0

2854

13052

UJF32

NOMESCO Finland

Coloscopy

12.1

323.0

4577

11198

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

5.1

323.0

2577

7464

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

18.4

323.0

583

347

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

15.8

323.0

800

575

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

7.8

323.0

1090

1650

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

13.2

323.0

925

807

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

25.8

323.0

2325

1391

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

11.8

323.0

1110

1123

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

17.0

323.0

639

414

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4503599627370496.0

323.0

6270

104

UJF30

NOMESCO Finland

Ileoscopy through colon

5.8

323.0

1437

3064

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

6.4

323.0

1461

2850

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

10.1

281.8

589

636

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.3

146.3

818

2705

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

12.3

139.1

259

218

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

137.7

2358

14253

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

123.2

1851

10488

A02BC02

ATC

pantoprazole; systemic

1.9

119.6

4316

33582

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

119.4

963

4015

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.3

106.1

584

1887

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

101.0

3103

22280

JFA42

NOMESCO Finland

Endoscopic injection in colon

22.0

90.7

134

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.8

90.1

620

2325

N02BE01

ATC

paracetamol; systemic, rectal

2.0

89.4

5458

47806

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

84.7

1484

8695

UJH02

NOMESCO Finland

Anoscopy

3.6

84.1

408

1189

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

79.6

868

4167

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

78.7

666

2810

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.1

78.7

476

1632

P01AB01

ATC

metronidazole; oral, rectal

1.7

75.6

2383

16733

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

75.3

828

3985

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

5.8

74.9

222

395

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

6.4

70.7

194

313

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

70.3

780

3759

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

7.0

67.8

174

256

K63.5

ICD-10 Finland

Polyp of colon

6.6

67.5

181

283

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

67.4

1145

6557

WX002

NOMESCO Finland

Sedation and analgesia

1.8

66.2

1385

8518

J01DB01

ATC

cefalexin; oral

1.7

62.8

4925

42902

A02BC03

ATC

lansoprazole; oral

1.7

62.6

1931

13292

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

12.9

62.2

112

B01AB05

ATC

enoxaparin; parenteral

1.6

61.7

2056

14439

A02BC05

ATC

esomeprazole; systemic

1.6

61.2

2525

18720

N02AX02

ATC

tramadol; systemic, rectal

1.6

61.1

2712

20470

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

16.9

60.8

K92.1

ICD-10 Finland

Melaena

2.7

60.6

455

1784

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

10.7

58.4

115

109

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

6.2

58.0

161

264

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

13.9

57.0

H02AB06

ATC

prednisolone; systemic

1.5

56.6

2893

22429

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

6.2

55.6

154

252

JN4BD

NOMESCO Finland

Extensive body CT

2.0

55.2

836

4560

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

9.7

55.1

114

119

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

51.7

876

4969

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

51.3

1686

11672

21136

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Coli sigmoidei

+∞

51.1

R03AC02

ATC

salbutamol; inhalant

1.5

49.8

2962

23488

R06.0

ICD-10 Finland

Dyspnoea

1.6

49.0

1608

11104

C05AA08

ATC

fluocortolone; rectal, topical

1.8

49.0

942

5569

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

45.7

48.2

S18

ICPC

Laceration/cut

1.5

47.0

2643

20618

R03BB04

ATC

tiotropium bromide; inhalant

1.9

43.0

721

4057

D01

ICPC

Abdominal pain/cramps general

2.0

42.4

579

3014

AA1AD

NOMESCO Finland

CT of head and brain

1.5

42.1

1570

11111

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

10.5

42.0

UJF34

NOMESCO Finland

Left colonoscopy

7.4

39.9

133

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

39.4

3837

32859

WX110

NOMESCO Finland

Local anesthesy

1.4

39.0

3799

32495

J01AA02

ATC

doxycycline; systemic

1.5

38.4

4664

41556

JN4AD

NOMESCO Finland

Body CT examination

2.0

38.2

555

2959

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

37.8

519

2705

C03CA01

ATC

furosemide; systemic

1.5

37.2

1923

14536

J01MA02

ATC

ciprofloxacin; systemic

1.4

36.9

2393

18909

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

36.7

2058

15804

J01CA04

ATC

amoxicillin; systemic

1.4

36.7

4541

40366

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

36.5

1684

12427

UJF92

NOMESCO Finland

Capsular endoscopy

3.7

36.3

165

456

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

36.2

2623

21134

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

35.8

1314

9209

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

35.8

561

3073

JFB30

NOMESCO Finland

Right hemicolectomy

4.0

35.0

145

370

N06AX11

ATC

mirtazapine; oral

1.5

34.8

1770

13298

K62.1

ICD-10 Finland

Rectal polyp

5.0

34.7

114

231

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

34.7

1016

6731

C07AB07

ATC

bisoprolol; oral

1.4

34.3

3071

25596

JFB46

NOMESCO Finland

Resection of sigmoid colon

4.4

34.3

127

292

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

34.2

2278

18009

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

33.8

1050

7057

N03AX16

ATC

pregabalin; oral

1.5

33.7

1386

9949

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.8

33.3

224

822

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

6.2

33.1

149

G47.3

ICD-10 Finland

Sleep apnoea

1.5

33.1

1238

8695

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.2

33.0

337

1546

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

33.0

898

5828

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

33.0

578

3286

R4110

NOMESCO Finland

Physiotherapy

1.5

32.6

1566

11600

A02BA02

ATC

ranitidine; systemic

1.5

32.1

1227

8647

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

4.0

32.0

131

331

J01FA06

ATC

roxithromycin; oral

1.4

31.8

2278

18178

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

31.5

576

3320

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

31.5

2689

22104

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

31.2

1010

6845

A06AD11

ATC

lactulose; oral

1.6

31.1

904

5964

J01DA01

ATC

[U] cefalexin; systemic

1.4

31.0

3549

30586

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

30.9

913

6050

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

30.5

1982

15510

D16

ICPC

Rectal bleeding

3.2

30.5

167

534

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

30.5

661

4019

N05CF01

ATC

zopiclone; oral

1.4

30.5

1926

14999

SPAT1263

SPAT

Sampling

1.4

30.4

2422

19636

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

30.2

235

938

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.6

30.2

222

859

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

30.2

251

1039

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.7

30.0

211

793

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

29.6

1245

8939

K55.2

ICD-10 Finland

Angiodysplasia of colon

6.2

29.5

133

A02BC01

ATC

omeprazole; systemic

1.4

29.5

1646

12512

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

29.5

303

1396

M79.6

ICD-10 Finland

Pain in limb

1.4

29.3

1982

15596

J01MA12

ATC

levofloxacin; systemic

1.5

29.3

1142

8069

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

29.1

1812

14047

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

7.1

29.0

103

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

28.9

833

5477

UKC02

NOMESCO Finland

Cystoscopy

1.5

28.5

1083

7596

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

28.4

474

2648

SPAT1104

SPAT

Monitoring of emergency patient

1.9

27.8

440

2413

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

8.4

27.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

27.3

870

5858

M54.5

ICD-10 Finland

Low back pain

1.4

27.1

1713

13274

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

27.1

2169

17502

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.9

27.0

172

609

C08CA01

ATC

amlodipine; oral

1.4

26.7

2267

18454

M25.5

ICD-10 Finland

Pain in joint

1.4

26.7

1454

10961

R01AD09

ATC

mometasone; nasal

1.4

26.6

2254

18342

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.6

26.6

196

761

SPAT1153

SPAT

Removal of sutures

1.4

26.5

1954

15542

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

26.4

1464

11070

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

26.3

342

1740

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

26.2

1435

10823

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

26.2

1061

7534

N06AB04

ATC

citalopram; systemic

1.5

26.2

1162

8412

UJG02

NOMESCO Finland

Proctoscopy

2.9

26.1

161

558

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

26.0

996

6984

N05BA04

ATC

oxazepam; oral

1.4

26.0

1341

10003

ICD-10 Finland

2.7

25.8

176

652

R53

ICD-10 Finland

Malaise and fatigue

1.5

25.8

1113

8010

G04CA02

ATC

tamsulosin; oral

1.4

25.4

1512

11568

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

25.4

428

2397

J02AC01

ATC

fluconazole; systemic

1.4

25.3

1888

15021

SPAT1301

SPAT

No procedures

1.4

25.2

1847

14647

C10AA05

ATC

atorvastatin; oral

1.3

25.2

2451

20327

H02AB04

ATC

methylprednisolone; systemic

1.6

25.1

809

5452

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.7

25.0

172

641

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

24.8

1806

14296

XKD00

NOMESCO Finland

Uroflowmetry

1.5

24.7

1072

7711

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.3

24.3

223

974

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

24.3

602

3792

H02AB07

ATC

prednisone; oral

1.5

24.1

821

5605

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

24.0

555

3431

R03BA02

ATC

budesonide; inhalant

1.5

24.0

914

6396

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

23.8

1494

11516

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

2.6

23.7

179

705

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

4.4

23.5

202

D11

ICPC

Diarrhoea

1.7

23.5

497

2994

M03BX02

ATC

tizanidine; oral

1.3

23.5

3276

28519

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

23.4

2690

22778

J45

ICD-10 Finland

Asthma

1.7

23.4

498

3006

A07EC02

ATC

mesalazine; oral, rectal

2.0

23.2

292

1468

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.8

23.0

149

536

C10AA01

ATC

simvastatin; oral

1.3

22.6

2841

24316

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

22.5

352

1920

K64.0

ICD-10 Finland

First degree haemorrhoids

3.7

22.4

265

D06

ICPC

Abdominal pain localized other

1.8

22.3

416

2408

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

7.0

22.3

J01FF01

ATC

clindamycin; systemic

1.4

22.3

1461

11330

K02.1

ICD-10 Finland

Caries of dentine

1.3

22.2

2792

23878

WX290

NOMESCO Finland

Other blockade of nerve

1.3

22.2

1941

15754

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

22.1

659

4355

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

21.9

1098

8112

Z01.7

ICD-10 Finland

Laboratory examination

1.6

21.9

596

3847

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

21.8

214

966

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

5.6

21.6

113

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

21.6

816

5687

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

21.6

643

4241

M02AA07

ATC

piroxicam; topical

1.3

21.6

2112

17413

E0000UV

ATC

1.3

21.5

2047

16804

R51.80

ICD-10 Finland

Headache

1.6

21.5

669

4464

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.6

21.1

152

584

R60.0

ICD-10 Finland

Localized oedema

1.6

21.1

657

4381

N06AX21

ATC

duloxetine; oral

1.6

20.9

513

3219

A06AC51

ATC

ispaghula, combinations; systemic

1.9

20.9

296

1561

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

20.9

5062

47227

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

20.8

295

1551

J20

ICD-10 Finland

Acute bronchitis

1.6

20.8

510

3201

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

20.8

747

5149

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

20.7

1441

11263

A10BA02

ATC

metformin; oral

1.3

20.6

1682

13479

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

20.5

843

5979

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

3.9

20.5

215

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

20.5

1384

10756

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

20.4

377

2174

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

20.3

3611

32174

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4.7

20.1

145

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

20.0

270

1396

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

20.0

2321

19543

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

19.9

2818

24354

B01AA03

ATC

warfarin; systemic

1.4

19.8

1286

9925

ZXA00

NOMESCO Finland

Right side

1.3

19.8

1603

12812

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

3.8

19.7

218

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

19.7

295

1586

K30

ICD-10 Finland

Functional dyspepsia

1.6

19.6

524

3363

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

19.5

367

2131

R03AC03

ATC

terbutaline; inhalant

1.5

19.4

705

4866

R05

ICD-10 Finland

Cough

1.4

19.4

1030

7674

N06AX16

ATC

venlafaxine; oral

1.6

19.3

599

3987

ZXA05

NOMESCO Finland

Left side

1.3

19.3

1501

11913

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

19.2

211

1005

T90

ICPC

Diabetes non-insulin dependent

1.3

19.1

1387

10894

K59.0

ICD-10 Finland

Constipation

1.8

18.9

319

1789

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

18.9

430

2642

N05CF02

ATC

zolpidem; oral

1.4

18.9

886

6445

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

18.9

184

830

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

18.8

291

1580

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

18.8

265

1395

R01AD08

ATC

fluticasone; nasal

1.3

18.8

1370

10763

R07.3

ICD-10 Finland

Other chest pain

1.6

18.8

520

3366

M48.0

ICD-10 Finland

Spinal stenosis

1.5

18.7

747

5261

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

17.1

18.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

18.6

3595

32194

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

18.6

1345

10550

R02

ICPC

Shortness of breath/dyspnoea

1.5

18.6

661

4542

SPAT1254

SPAT

Administration of medicine

1.5

18.6

812

5826

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

18.5

513

3320

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

18.5

747

5272

M01AE02

ATC

naproxen; oral, rectal

1.3

18.5

2939

25680

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

18.5

237

1203

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

18.4

618

4191

A04

ICPC

Weakness/tiredness general

1.5

18.4

658

4525

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

18.4

343

1984

L03

ICPC

Low back symptom/complaint

1.4

18.4

1214

9378

ZX120

NOMESCO Finland

Intravenous

1.6

18.3

537

3527

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4.1

18.3

174

R03DC03

ATC

montelukast; oral

1.5

18.2

745

5270

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

18.2

368

2185

J01FA09

ATC

clarithromycin; systemic

1.3

18.1

1557

12522

M01AX17

ATC

nimesulide; oral

1.3

18.1

1406

11139

A98

ICPC

Health maint/preventive medicine

1.4

18.1

5694

54475

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

18.0

927

6855

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

18.0

265

1416

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.8

18.0

117

425

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.1

18.0

218

1082

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

18.0

521

3414

A01

ICPC

Pain general/multiple sites

1.7

18.0

404

2474

N30.0

ICD-10 Finland

Acute cystitis

1.5

17.9

690

4821

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

17.9

799

5751

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

17.8

557

3713

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

17.7

3147

27816

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

17.7

222

1115

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

17.6

928

6890

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

4.0

17.4

178

K29.8

ICD-10 Finland

Duodenitis

3.9

17.3

188

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

17.3

970

7281

Z01.2

ICD-10 Finland

Dental examination

1.3

17.3

1950

16268

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

17.3

940

7019

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

17.1

1379

10974

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

17.0

362

2182

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

17.0

913

6799

C187, 8211, 2

ICD-O-3

31.5

17.0

N03AX12

ATC

gabapentin; oral

1.4

17.0

818

5973

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

16.9

180

846

A07EA06

ATC

budesonide; oral, local oral

2.2

16.9

175

813

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

16.9

343

2040

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

16.8

716

5106

JF2BD

NOMESCO Finland

Extensive colon CT

3.3

16.7

251

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

16.7

367

2235

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.3

16.6

160

719

K57

ICD-10 Finland

Diverticular disease of intestine

2.4

16.6

140

589

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

16.5

2094

17704

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

9.5

16.3

L04AX01

ATC

azathioprine; systemic

2.0

16.3

216

1110

L01BC06

ATC

capecitabine; oral

2.0

16.3

212

1084

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

16.2

411

2600

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

16.2

868

6461

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

16.1

1528

12430

A08

ICPC

Swelling

1.9

16.1

249

1356

N06AB10

ATC

escitalopram; oral

1.4

16.1

820

6048

R03AC13

ATC

formoterol; inhalant

1.8

15.9

270

1515

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

15.9

923

6964

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

5.8

15.8

XF402

NOMESCO Finland

ECG with work load test

1.5

15.8

667

4746

K60.1

ICD-10 Finland

Chronic anal fissure

2.4

15.7

128

529

WX892

NOMESCO Finland

Monitored bed care

1.6

15.7

432

2789

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

15.7

1454

11781

N05BA01

ATC

diazepam; systemic, rectal

1.4

15.7

696

4999

UJD02

NOMESCO Finland

Gastroscopy

1.8

15.7

281

1607

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

15.5

1566

12832

A01AB09

ATC

miconazole; local oral

1.6

15.5

459

3021

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

4.1

15.4

149

SPAT1210

SPAT

Application of cast or individual aid

1.9

15.4

225

1200

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

15.3

1632

13476

N07BA03

ATC

varenicline; oral

1.9

15.3

230

1241

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

3.2

15.2

248

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

15.2

1617

13342

R42

ICD-10 Finland

Dizziness and giddiness

1.3

15.1

1201

9516

G44.2

ICD-10 Finland

Tension-type headache

1.5

15.1

583

4071

R03BA01

ATC

beclometasone; inhalant

1.4

15.0

715

5203

G04CA01

ATC

alfuzosin; oral

1.4

15.0

715

5205

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

15.0

578

4037

J01MA14

ATC

moxifloxacin; systemic

1.5

14.8

471

3151

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

14.8

466

3109

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

14.7

253

1430

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.2

14.7

142

640

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

14.7

265

1520

D18

ICPC

Change in faeces/bowel movements

2.3

14.7

138

612

D64.8

ICD-10 Finland

Other specified anaemias

2.7

14.7

103

391

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

9.1

14.6

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

2.3

14.6

135

594

M10.9

ICD-10 Finland

Gout, unspecified

1.6

14.6

391

2511

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

14.6

356

2232

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

14.6

841

6330

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

14.6

540

3736

R52.9

ICD-10 Finland

Pain, unspecified

1.6

14.6

415

2706

WZA90

NOMESCO Finland

Other doctors statement

1.3

14.5

1095

8600

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

2718

6724

5.86

307.65

1.5

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1655

7285

2.65

236.05

4.4

4.1

ug/l

29.3

26.2

0.06

1402

6008

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4664

33376

2.11

192.90

6.9

6.3

umol/l

11.4

11.8

1.10

4449

31681

(40768804) Tissue Pathology biopsy report

3687

24815

1.99

173.38

2.5

2.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2696

16310

2.04

171.32

2.8

2.3

mg/l

3.4

3.0

8.14

2379

13847

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6006

48405

2.38

170.94

9.6

7.8

u/l

79.8

79.6

0.15

5745

45412

(3024561) Albumin [Mass/volume] in Serum or Plasma

4066

28389

1.98

170.91

5.8

4.9

g/l

35.1

35.0

0.56

3854

26228

(40768797) Stomach Pathology biopsy report

1708

8699

2.26

169.78

1.3

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3911

27320

1.93

159.92

2.3

2.0

pmol/l

94.4

0.01

2235

14110

(3048689) Calprotectin [Mass/mass] in Stool

1330

6288

2.36

156.17

2.2

2.1

ug/g

139.8

153.6

0.84

1068

4859

(3044640) Blood type and Crossmatch panel - Blood

3026

20051

1.87

139.17

3.0

2.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2466

15326

1.92

138.07

2.9

2.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5606

45273

2.04

137.82

5.1

4.2

mm/h

14.3

13.4

3.56

5200

41523

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3016

20117

1.85

134.53

3.0

2.6

u/l

57.7

58.8

0.39

2802

18506

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3459

24083

1.83

134.08

3.7

2.8

ug/l

126.4

155.5

7.82

3229

21940

(3013650) Neutrophils [#/volume] in Blood by Automated count

4603

35332

1.83

125.61

10.1

9.1

e9/l

4.3

4.2

0.78

4035

30658

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4054

29976

1.80

125.27

7.4

6.1

mmol/l

1.2

1.84

3700

26997

(3031040) Bacteria [#/volume] in Urine by Automated count

5143

41032

1.87

121.61

5.7

4.8

e6/l

344.6

1797.0

4.22

640

(3006315) Basophils [#/volume] in Blood

4085

30442

1.78

121.19

6.8

5.8

e9/l

0.0

1.58

3543

26001

(3001604) Monocytes [#/volume] in Blood

4063

30263

1.78

120.42

6.8

5.7

e9/l

0.6

0.07

3523

25817

(3019198) Lymphocytes [#/volume] in Blood

4135

30986

1.78

119.72

6.8

5.8

e9/l

1.9

0.40

3614

26929

(3013115) Eosinophils [#/volume] in Blood

4178

31413

1.78

119.46

7.0

5.9

e9/l

0.2

0.28

3660

27230

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1919

11467

1.91

117.48

1.3

1.2

u/ml

1.5

1.9

0.72

451

2939

(3011397) Hemoglobin [Presence] in Urine by Test strip

2278

14395

1.85

116.97

4.7

3.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3914

29084

1.75

114.59

4.6

4.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5223

42392

1.82

110.37

5.4

4.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4745

37830

1.73

102.21

6.0

4.8

mmol/l

6.9

6.8

0.96

4499

35602

(3022948) Iron [Moles/volume] in Serum or Plasma

1735

10436

1.87

101.85

3.1

2.6

umol/l

11.9

12.6

3.66

1631

9603

(3007164) IgA [Mass/volume] in Serum or Plasma

1700

10167

1.88

101.57

1.5

g/l

2.6

0.00

941

5949

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4258

33015

1.70

101.11

8.5

6.9

mmol/l

1.2

5.19

3768

27717

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6671

59602

2.45

97.85

23.0

16.1

mg/l

26.4

25.6

1.11

5729

48131

(3033658) Prothrombin time (PT) actual/Normal

2390

16079

1.72

94.77

5.1

4.0

88.1

87.3

0.79

2342

15695

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1606

9692

1.84

92.00

3.1

2.5

g/l

2.3

3.13

1515

8919

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1526

9104

1.86

90.51

3.2

2.6

20.5

22.2

4.90

1369

7646

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

759

3610

2.23

84.43

2.6

2.5

—

(3032080) INR in Blood by Coagulation assay

3629

27763

1.61

84.05

10.8

10.1

inr

1.3

0.08

727

7707

(3014576) Chloride [Moles/volume] in Serum or Plasma

1438

8602

1.84

83.79

7.9

6.9

mmol/l

104.5

104.4

0.24

1424

8414

(40758558) Short blood count panel - Blood

2271

15477

1.68

83.51

7.4

6.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1343

7926

1.85

81.48

2.5

1.8

0.98

1217

6960

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1756

11291

1.73

79.38

3.1

2.9

e6/l

1.2

1.4

0.48

1091

6596

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5295

44819

1.67

77.96

4.4

4.0

pmol/l

15.0

0.38

4814

40149

(3000991) Gas panel - Venous blood

1022

5590

1.96

77.92

8.7

8.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

849

4363

2.07

77.06

8.6

8.8

93.6

93.9

0.95

849

4347

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

917

4860

2.01

76.42

1.7

1.6

—

(42870588) Differential panel, method unspecified - Blood

2892

21327

1.59

75.38

6.6

5.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6159

54532

1.85

75.13

5.6

4.8

mu/l

2.3

2.1

0.23

5668

49131

(3021960) Folate [Moles/volume] in Serum or Plasma

2260

15745

1.63

74.36

1.7

1.6

nmol/l

21.0

20.4

0.75

1985

13340

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1088

6178

1.89

73.85

2.5

2.2

g/l

0.2

6.44

1027

5726

(3019309) Folate [Moles/volume] in Red Blood Cells

1963

13226

1.66

73.59

1.8

nmol/l

1142.6

1167.2

0.50

1531

9884

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1035

5790

1.92

73.50

2.6

2.4

u/l

31.6

46.5

1.11

894

4950

(3035350) Ketones [Presence] in Urine by Test strip

3769

29697

1.56

72.51

4.6

3.9

estimate

0.0

0.50

437

5523

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2813

20757

1.58

72.24

3.5

3.1

ng/l

1481.9

1555.3

0.31

2496

18003

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

678

3273

2.18

72.23

1.6

1.7

g/l

1.6

0.88

591

2793

(3018095) Leukocytes [#/volume] in Urine

3015

22628

1.57

71.75

4.4

3.9

e6/l

77.5

111.3

1.64

2181

16445

(3015377) Calcium [Moles/volume] in Serum or Plasma

2940

21960

1.57

71.32

3.7

3.4

mmol/l

2.4

0.00

2529

18850

(40761535) Cells panel - Urine sediment

993

5541

1.92

70.88

4.6

3.6

—

(3023368) Bacteria identified in Blood by Culture

2577

18703

1.59

70.66

4.8

4.4

—

(3009261) Glucose [Presence] in Urine by Test strip

3804

30145

1.55

70.50

4.7

3.9

estimate

0.0

0.20

436

5410

(3019069) Monocytes/100 leukocytes in Blood

3640

28607

1.55

69.75

7.4

6.4

8.8

8.9

0.21

3417

26567

(3006504) Eosinophils/100 leukocytes in Blood

3621

28454

1.54

69.22

7.0

6.1

2.8

2.9

0.60

3388

26330

(3018010) Neutrophils/100 leukocytes in Blood

3647

28711

1.54

69.08

6.9

5.9

58.1

58.0

0.31

3396

26620

(3014765) Yersinia sp identified in Stool by Organism specific culture

411

1626

2.62

68.53

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

412

1633

2.61

68.44

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1927

13149

1.63

67.71

5.4

4.4

kg/l

1.0

0.28

310

1994

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

407

1613

2.61

67.61

1.3

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

3744

29793

1.53

66.42

6.1

5.2

estimate

0.0

0.80

455

5576

(3023520) Reticulocytes [#/volume] in Blood

1046

6055

1.85

66.28

2.6

2.5

e9/l

70.4

69.0

0.63

825

4623

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3287

25444

1.53

66.26

4.8

3.9

ng/l

38.2

78.1

1.47

2507

18897

(3002030) Lymphocytes/100 leukocytes in Blood

3676

29153

1.53

66.15

7.2

6.2

26.4

26.8

1.36

3412

26891

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1339

8356

1.74

65.77

10.6

7.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1025

5936

1.85

64.75

7.5

6.7

mmol/l

1.3

0.59

996

5717

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4502

37386

1.54

64.65

4.1

3.2

u/l

58.5

53.2

2.77

4166

34243

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1176

7129

1.77

63.74

2.9

2.7

umol/l

8.5

8.8

0.20

1046

6234

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1803

12285

1.62

62.94

3.5

3.2

mmol/l

2.5

0.27

1591

10708

(3030467) Casts [#/volume] in Urine by Automated count

2483

18258

1.55

62.25

3.7

3.3

e6/l

0.4

0.5

1.25

1911

13869

(3022096) Basophils/100 leukocytes in Blood

3495

27678

1.51

61.57

7.1

6.1

0.7

1.91

3266

25628

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1055

6254

1.80

61.50

2.7

2.4

ug/l

6.7

7.3

0.47

924

5400

(3019550) Sodium [Moles/volume] in Serum or Plasma

6776

62762

2.17

60.92

26.9

18.9

mmol/l

139.6

139.7

1.12

6684

61232

(3003396) Base excess in Arterial blood by calculation

1279

8054

1.71

60.25

7.2

7.0

mmol/l

0.7

1.1

2.63

1016

6264

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2686

20243

1.52

59.33

2.3

2.2

u/l

205.3

212.7

0.14

2518

18893

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1276

8094

1.70

58.31

7.3

7.0

kpa

5.1

0.53

1228

7706

(3023103) Potassium [Moles/volume] in Serum or Plasma

6776

62900

2.14

58.30

27.1

19.0

mmol/l

4.0

0.18

6681

61270

(36304419) Bacteria [Presence] in Urine

2385

17576

1.53

58.25

3.7

3.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1275

8090

1.70

58.19

7.3

7.0

kpa

12.1

0.20

1220

7698

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3201

25115

1.49

57.64

2.5

2.2

nmol/l

78.2

79.1

0.95

2847

22171

(3007853) Bacteria identified in Skin by Aerobe culture

1182

7371

1.72

57.43

1.9

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

488

2270

2.23

56.61

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1344

8743

1.66

55.51

7.2

5.8

mmol/l

1.1

1.0

1.62

1263

8091

(3042936) Bacteria identified in Isolate by Culture

1400

9215

1.64

55.17

2.3

2.0

—

(3016502) Oxygen saturation in Arterial blood

1158

7288

1.70

54.10

7.4

7.3

95.4

95.5

0.21

1129

6999

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6229

56606

1.70

53.25

19.9

15.2

ml/min/173m2

75.5

76.1

1.11

5337

47058

(4010399)

802

4556

1.85

53.24

1.5

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1540

10470

1.60

52.87

3.4

3.1

e6/l

2.6

2.2

0.89

887

5810

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1854

13176

1.55

52.35

2.0

1.7

mg/l

1.2

1.4

0.83

1447

10251

(3026493) Urate [Moles/volume] in Serum or Plasma

2307

17186

1.50

52.17

3.1

2.8

umol/l

4875.2

5046.1

0.06

1997

14671

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6221

56600

1.69

51.86

7.6

6.3

mmol/mol

40.9

40.5

2.10

5799

51757

(3022217) INR in Platelet poor plasma by Coagulation assay

1422

9524

1.61

51.84

33.3

27.2

inr

1.5

1.4

0.93

153

1326

(3002032) Base excess in Venous blood by calculation

1014

6235

1.73

51.36

4.5

3.8

mmol/l

1.7

2.0

1.32

844

5061

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1068

6674

1.70

50.97

7.9

7.8

g/l

119.6

120.7

1.01

1042

6420

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1015

6257

1.72

50.91

4.5

3.8

kpa

5.8

0.09

980

6079

(40761511) CBC panel - Blood by Automated count

6612

61295

1.87

50.46

21.7

15.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6776

63354

2.02

49.94

14.8

11.2

u/l

25.8

26.0

0.38

6600

60815

(3020779) Urea [Moles/volume] in Serum or Plasma

1004

6220

1.71

49.34

9.1

7.1

mmol/l

10.6

10.5

0.08

956

5922

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2523

19309

1.47

49.13

3.5

3.3

u/l

32.4

35.8

1.90

2365

18220

(3002582) Erythrocytes [#/volume] in Urine

2567

19841

1.45

46.90

3.9

3.4

e6/l

103.0

97.2

0.05

2009

15369

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

656

3642

1.88

46.54

9.4

8.9

mmol/l

24.1

24.3

0.80

614

3387

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

842

5057

1.75

46.05

4.6

3.8

ng/l

98.3

95.1

0.42

745

4294

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1570

11028

1.54

45.80

2.1

1.9

—

(3020891) Body temperature

533

2781

1.99

45.47

5.5

4.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1202

7955

1.61

45.38

4.1

4.2

u/l

235.2

245.1

1.33

1146

7481

(3020682) Albumin/Creatinine [Ratio] in Urine

2745

21580

1.44

45.36

4.3

4.0

mg/mmol

10.2

9.2

0.50

1843

13553

(3000570) Elastase.pancreatic [Mass/mass] in Stool

409

1939

2.18

45.10

1.5

1.4

ug/g

262.4

267.0

0.18

249

1181

(3025941) Bacteria identified in Stool by Culture

571

3083

1.92

44.04

1.4

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

946

5940

1.68

43.86

2.5

2.6

g/l

66.2

0.03

862

5345

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1489

10438

1.54

43.54

2.3

2.0

30.0

0.16

1439

10129

(3003327) Ova and parasites identified in Stool by Light microscopy

358

1631

2.26

43.53

1.7

—

(36660697) Celiac disease serology panel - Serum

715

4159

1.80

43.52

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

2664

20947

1.43

43.44

3.5

3.2

mmol/l

7.5

7.4

0.47

2247

17324

(3024354) Oxygen [Partial pressure] in Venous blood

842

5136

1.72

43.43

3.7

3.2

kpa

4.6

4.5

0.21

811

4967

(3013512) EKG study

2516

19586

1.44

43.33

4.8

4.2

—

(3012516) Albumin [Mass/volume] in Urine

2611

20476

1.43

43.12

3.6

3.2

mg/l

383.5

376.1

0.03

1760

12982

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1534

10899

1.52

41.91

3.7

3.2

mmol/l

0.8

1.22

1446

10150

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

842

5184

1.71

41.90

2.5

2.7

ml/min/173m2

62.6

0.01

362

2100

(3000850) Epithelial cells [#/volume] in Urine

1882

13972

1.47

41.28

2.8

2.7

e6/l

4.2

4.9

2.57

1626

12231

(3020961) Endomysium IgA Ab [Titer] in Serum

451

2296

2.03

41.15

1.1

titre

135.8

172.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

562

3101

1.88

40.47

4.3

4.0

mmol/l

24.1

24.2

0.09

499

2767

(3018418) pH of Serum or Plasma

2501

19652

1.42

40.05

5.2

4.1

7.4

0.46

310

3781

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

691

4094

1.76

39.34

1.9

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6475

60403

1.66

38.55

6.1

5.3

mmol/l

2.6

2.7

8.25

6016

54919

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3675

30940

1.38

38.46

2.6

2.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6136

56553

1.54

38.13

4.8

4.2

mmol/l

1.4

1.3

10.73

5616

50820

(3007461) Platelets [#/volume] in Blood

6864

65171

1.95

37.60

35.0

23.7

e9/l

247.2

244.4

2.71

6757

63339

(3010813) Leukocytes [#/volume] in Blood

6866

65199

1.95

37.55

35.0

23.7

e9/l

7.0

6.8

7.34

6747

63118

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

461

2443

1.95

37.46

1.1

—

(3024731) MCV [Entitic volume]

6864

65186

1.95

37.34

34.9

23.6

91.5

0.50

6805

64126

(3026361) Erythrocytes [#/volume] in Blood

6864

65190

1.95

37.27

35.0

23.7

e12/l

4.4

10.64

6742

63124

(3026008) Bacteria identified in Urine by Culture

2492

19754

1.40

37.21

3.7

3.3

—

(3035941) MCH [Entitic mass]

6863

65185

1.94

37.14

34.8

23.6

30.3

30.4

5.07

6804

64125

(3000963) Hemoglobin [Mass/volume] in Blood

6864

65200

1.94

37.10

35.3

23.8

g/l

132.2

134.5

29.65

6805

64149

(3013139) Helicobacter pylori Ag [Presence] in Stool

663

3950

1.75

36.93

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

794

4972

1.67

36.82

2.3

2.4

—

(3037522) Nuclear Ab [Titer] in Serum

1109

7568

1.55

35.91

1.4

1.3

titre

415.9

516.6

1.62

242

1614

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6330

58925

1.57

35.68

6.0

5.0

mmol/l

6.1

5.76

5861

53022

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

399

2054

2.00

35.23

1.7

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1109

7617

1.54

34.77

2.0

1.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6283

58496

1.55

34.21

5.3

4.7

mmol/l

1.4

1.5

7.00

5821

53069

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6321

58978

1.55

33.52

5.4

4.7

mmol/l

4.5

4.6

8.54

5880

53895

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

458

2515

1.88

33.36

3.4

u/ml

522.7

2520.8

1.04

393

2151

(3009542) Hematocrit [Volume Fraction] of Blood

5706

52225

1.43

32.87

24.4

17.4

38.7

39.3

4.20

3745

34258

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1097

7608

1.52

32.71

2.0

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

437

2382

1.89

32.56

2.5

2.3

ug/l

413.5

670.1

1.14

413

2257

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

535

3106

1.78

32.48

3.2

2.7

0.7

0.18

510

2972

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

450

2481

1.87

32.35

2.9

3.0

u/ml

0.3

0.53

266

1411

(3043409) Potassium [Moles/volume] in Arterial blood

395

2107

1.92

31.42

4.4

mmol/l

3.8

3.9

2.06

387

1976

(3000492) Spirometry study

804

5256

1.60

31.09

1.7

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

632

3907

1.68

30.56

1.6

1.5

—

(3019060) Gas panel - Arterial blood

741

4775

1.61

30.39

4.2

4.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

325

1645

2.02

30.07

1.5

1.6

—

(3000494) Fungus identified in Specimen by Culture

1038

7245

1.50

29.79

1.6

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

465

2672

1.79

29.18

4.7

3.8

mmol/l

24.7

24.9

0.86

438

2429

(3019225) pH of Specimen

984

6831

1.51

28.93

5.0

4.5

—

(3026782) Osmolality of Urine

1688

12972

1.39

28.76

3.1

2.9

mosm/kgh2o

548.8

548.2

0.03

1388

11035

(3022313) Gas panel - Capillary blood

518

3095

1.73

28.36

4.6

3.7

—

(3002256) Pathology report gross observation

1150

8286

1.46

28.00

1.4

1.3

—

(3037121) Protein [Mass/volume] in Urine

394

2196

1.84

27.33

3.2

3.0

g/l

0.4

0.3

0.63

178

902

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

848

5790

1.53

26.84

1.9

1.7

1.6

1.5

2.74

714

4955

(3017143) Hepatitis C virus Ab [Presence] in Serum

778

5232

1.55

26.38

1.7

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1237

9144

1.43

26.05

1.3

1.2

u/ml

11.5

13.5

0.43

455

3341

(3044889) 12 lead EKG panel

4882

44164

1.32

25.87

5.0

4.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2720

22751

1.31

25.81

5.2

4.2

—

(4035726)

848

5872

1.50

25.01

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

472

2850

1.70

24.82

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

472

2851

1.70

24.79

2.3

g/l

7.5

0.22

348

2105

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

471

2844

1.70

24.77

2.3

g/l

3.9

3.8

0.17

333

2016

(3003338) MCHC [Mass/volume]

5266

48283

1.33

24.55

31.5

21.0

g/l

330.6

331.9

20.91

5229

47895

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1676

13149

1.36

24.48

4.5

4.0

ng/l

504.9

501.8

0.01

1401

10958

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

324

1764

1.88

24.20

1.7

1.4

iu/ml

10.9

16.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

610

3957

1.59

24.15

8.6

7.0

mmol/l

24.8

0.07

603

3926

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

361

2036

1.81

24.09

1.4

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

779

5341

1.51

24.05

2.5

2.3

nmol/l

365.7

373.7

0.48

720

4893

(3004119) Hemoglobin [Mass/volume] in Venous blood

634

4166

1.57

23.74

3.7

3.4

g/l

124.3

128.4

4.16

623

4063

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

377

2167

1.78

23.60

1.6

titre

146.0

308.1

—

102

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1283

9708

1.39

23.35

1.3

iu/ml

29.7

37.2

1.26

369

2985

(3009445) Proteinase 3 Ab [Units/volume] in Serum

459

2799

1.68

23.25

1.6

1.5

u/ml

13.1

20.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

440

2657

1.70

23.12

2.3

g/l

10.2

10.3

0.11

374

2216

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

2654

1.70

22.97

2.3

2.4

g/l

3.1

0.34

344

2056

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

804

5599

1.49

22.96

1.7

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

2013

16372

1.32

22.69

5.6

4.3

estimate

0.0

1.79

443

5307

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

403

2408

1.71

22.01

2.4

g/l

1.0

0.00

352

2044

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

646

4352

1.53

21.57

4.5

3.6

kpa

5.1

5.2

0.84

603

4002

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

360

2112

1.74

21.00

2.4

2.3

g/l

0.0

0.29

330

1916

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

251

1321

1.93

20.81

1.7

1.6

—

(3009343) pH of Capillary blood

633

4293

1.52

20.46

4.5

3.6

7.4

1.71

553

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

613

4137

1.53

20.27

4.5

3.5

mmol/l

1.2

1.9

3.89

481

3066

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

336

1972

1.74

19.58

2.4

2.3

g/l

0.0

0.29

306

1783

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

331

1936

1.74

19.53

2.4

2.3

g/l

0.0

0.00

306

1777

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

366

2215

1.69

19.07

2.3

2.2

g/l

37.5

37.4

0.14

318

1877

(3052851) Hemolysis interference index of Serum or Plasma

334

1976

1.72

18.92

4.2

3.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

100

373

2.70

18.90

1.7

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

260

1434

1.84

18.69

1.5

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

647

4501

1.48

18.43

7.1

7.0

mmol/l

24.6

0.09

612

4187

(46235355) HIV 1 and 2 tests - Meaningful Use set

872

6415

1.41

18.38

1.7

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

219

1158

1.92

17.95

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

524

3511

1.53

17.88

1.9

g/l

1.4

0.03

485

3158

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

246

1358

1.84

17.65

1.4

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1067

8168

1.36

17.61

4.8

32.6

32.9

0.32

769

5398

(3007566) Smooth muscle Ab [Titer] in Serum

275

1573

1.78

17.55

1.2

titre

121.5

174.4

0.38

126

(3021589) Normoblasts [#/volume] in Blood

3050

26726

1.24

17.53

11.6

10.2

e9/l

0.0

0.96

2473

21793

(3034770) Mitochondria Ab [Titer] in Serum

275

1578

1.77

17.36

1.2

titre

1223.3

898.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

501

3350

1.53

17.25

4.4

3.5

mmol/l

24.9

25.2

1.31

493

3250

(3005719) IgG [Mass/volume] in Serum or Plasma

635

4480

1.46

16.80

2.6

2.7

g/l

10.6

10.5

0.22

591

4076

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

387

2469

1.60

16.38

2.5

2.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

165

820

2.04

16.20

1.4

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

375

2381

1.61

16.19

3.0

3.4

mg/l

55.3

82.4

0.58

331

1943

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

373

2379

1.60

15.81

3.0

3.4

mg/l

41.0

52.2

0.92

329

1941

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

365

2326

1.60

15.53

1.5

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

364

2323

1.60

15.39

3.0

3.3

ratio

1.3

3.1

1.53

179

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

555

3883

1.46

15.31

10.6

9.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

371

2.50

14.94

2.5

2.1

umol/l

13.7

32.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

164

839

1.98

14.88

1.6

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

338

2140

1.61

14.78

1.1

u/ml

1.0

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

163

842

1.96

14.40

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

163

842

1.96

14.40

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

163

845

1.95

14.25

1.6

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

190

1037

1.85

14.21

1.4

1.3

u/l

10.5

11.1

0.24

149

841

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

165

861

1.94

14.15

1.6

1.4

—

(3049717) Cytology report of Urine Cyto stain

427

2880

1.51

14.12

2.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

121

566

2.16

13.99

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

121

566

2.16

13.99

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

121

566

2.16

13.99

1.6

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

327

2084

1.60

13.93

1.5

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

162

849

1.93

13.73

1.6

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2817

24939

1.21

13.44

5.6

5.2

ug/l

2.8

3.4

0.90

2557

22250

(21494890) Protein electrophoresis panel - 24 hour Urine

151

779

1.96

13.42

1.7

2.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

239

1421

1.70

13.38

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

239

1421

1.70

13.38

1.5

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

279

1729

1.64

13.34

2.8

2.4

g/l

3.7

3.6

0.80

266

1644

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

281

1747

1.63

13.26

1.5

g/l

1.2

0.00

268

1651

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

390

2616

1.52

13.25

1.9

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

248

1494

1.68

13.23

2.9

3.3

u/ml

147.5

690.2

2.04

227

1361

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

279

1733

1.63

13.22

2.4

2.1

90.4

89.1

0.41

261

1635

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

275

1702

1.64

13.22

1.5

1.6

iu/ml

0.1

8.6

1.23

388

(40760892) CBC W Ordered Manual Differential panel - Blood

1510

12548

1.26

13.13

5.1

4.7

—

(3042733) HLA Ab [Presence] in Serum

151

3.26

13.08

5.2

5.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

273

1692

1.64

13.05

1.5

g/l

0.2

0.65

262

1598

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

900

7009

1.32

12.98

1.4

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

429

2955

1.48

12.81

2.0

1.9

ug/l

1.9

2.3

0.35

386

2588

(3024928) Oxygen saturation in Venous blood

233

1396

1.69

12.70

2.5

3.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

414

2844

1.48

12.54

2.1

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

126

634

2.00

12.07

1.9

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

132

677

1.97

11.98

1.9

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

164

904

1.83

11.95

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

133

685

1.96

11.92

4.1

3.3

—

(3006462) Nitrate [Presence] in Urine

301

2.47

11.89

5.0

3.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

473

3373

1.43

11.79

1.5

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

805

6260

1.32

11.68

3.0

2.9

ng/l

221.6

217.3

0.10

733

5739

(3000475) Leukocytes [#/volume] in Synovial fluid

260

1641

1.61

11.59

1.7

1.6

e6/l

16115.0

13903.6

0.24

185

1169

(1761868) Lipid panel - Serum or Plasma

1613

18857

0.81

11.52

3.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

128

660

1.96

11.46

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

157

867

1.83

11.40

1.5

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

226

2.67

11.29

34.7

33.2

ug/l

7.1

7.3

0.26

204

(3036489) Thrombin time

327

2189

1.52

11.25

2.2

1.9

22.0

21.7

0.32

294

1933

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

130

681

1.93

11.12

3.8

3.6

—

(4211845)

331

2.34

10.99

4.9

3.5

—

(3044927) Protein electrophoresis panel - Urine

137

735

1.88

10.91

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

227

1411

1.63

10.79

3.9

2.6

umol/l

35.9

34.3

0.36

202

1177

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

378

2.24

10.79

1.3

1.2

u/l

83.3

84.9

0.06

330

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2268

19985

1.20

10.71

5.1

4.5

22.1

0.09

1219

10332

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

265

1714

1.57

10.67

2.4

2.3

ug/min

138.0

109.7

0.45

145

995

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

759

5935

1.31

10.56

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

200

1211

1.67

10.55

6.1

5.2

iu/ml

858.8

2472.9

0.56

184

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

430

2.13

10.37

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

176

1036

1.72

10.32

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

476

3484

1.39

10.23

1.3

au/ml

72.2

53.9

0.62

155

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

230

1457

1.60

10.14

1.7

nmol/l

41.8

43.0

0.31

221

1393

(3051651) Icteric interference index of Serum or Plasma

377

2.19

10.03

4.0

3.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

442

3207

1.40

10.01

1.3

u/ml

308.0

230.6

0.30

406

2929

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

128

692

1.86

10.00

1.3

1.2

u/l

55.3

60.8

0.38

459

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

105

531

1.99

9.99

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

340

2.25

9.93

1.5

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

246

1592

1.56

9.91

2.6

2.4

197.5

202.1

0.37

234

1514

(3027456) Digoxin [Moles/volume] in Serum or Plasma

234

1499

1.58

9.85

3.4

3.1

nmol/l

0.8

0.67

180

1147

(40768443) Skin Pathology biopsy report

410

2945

1.42

9.84

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

368

2.19

9.78

1.3

1.2

u/l

21.7

0.00

315

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

159

925

1.73

9.74

6.8

6.4

mg/l

12.3

11.9

0.48

150

847

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

343

2.23

9.73

1.5

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

514

3841

1.36

9.73

2.5

2.4

au/ml

21.1

24.2

0.19

152

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

157

911

1.74

9.71

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

452

3313

1.39

9.64

3.1

3.3

pmol/l

4.3

4.4

0.77

405

2895

(3024932) HLA-DR beta [Type]

149

2.90

9.51

1.1

—

(3037756) Immunofixation for Serum or Plasma

242

1576

1.55

9.50

1.5

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

151

876

1.74

9.36

2.6

2.1

mg/l

29.2

26.7

0.19

209

(40760888) Immunoglobulin light chains.free panel - Serum

268

1795

1.51

9.26

2.9

3.5

—

(3003694) ABO and Rh group [Type] in Blood

1765

15377

1.20

9.18

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

213

1365

1.58

8.99

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

391

2832

1.40

8.97

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

285

2.29

8.95

1.1

1.0

—

(3024471) HLA-A [Type]

155

2.78

8.88

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

212

1364

1.57

8.80

1.1

u/ml

1.7

10.6

2.85

123

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

136

780

1.76

8.80

1.1

g/l

1.5

0.06

124

697

(3028308) Erythrocytes [#/volume] in Pleural fluid

140

811

1.74

8.75

1.6

1.5

e6/l

66179.1

58301.2

0.10

476

(3017446) Testosterone [Moles/volume] in Serum or Plasma

583

4515

1.32

8.69

2.4

2.1

nmol/l

12.1

12.5

0.67

507

3928

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

461

1.99

8.68

1.5

1.3

u/l

28.3

34.4

1.02

372

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

271

1846

1.49

8.65

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

186

1166

1.61

8.63

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

173

1071

1.63

8.45

1.8

pmol/l

178.3

200.4

2.35

157

1009

(3014148) Varicella zoster virus Ab [Titer] in Serum

474

1.95

8.38

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

306

2153

1.44

8.28

1.2

u/ml

0.2

0.9

2.49

208

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1635

14271

1.19

8.19

3.4

3.1

ug/l

0.7

0.8

0.65

1249

9982

(3010375) cycloSPORINE [Mass/volume] in Blood

252

2.31

8.19

31.7

25.8

ug/l

114.5

109.4

0.31

208

(3044941) Cell count panel - Synovial fluid

166

1028

1.63

8.12

1.5

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

149

899

1.67

8.07

1.6

1.5

e6/l

2160.9

2076.1

0.06

103

652

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

132

772

1.72

8.02

1.2

u/ml

3.0

4.3

1.24

329

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

113

632

1.80

8.00

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

332

2.12

8.00

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

332

2.12

8.00

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

150

910

1.66

7.96

1.6

1.4

u/ml

108.3

119.2

0.67

198

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

134

792

1.70

7.85

1.2

u/ml

1.6

3.4

2.44

253

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

254

2.25

7.61

2.8

2.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

227

1538

1.49

7.49

1.5

—

(3045424) Erythrocytes [Presence] in Urine

166

1050

1.59

7.48

1.6

1.5

—

(3036603) Volume of Urine

438

1.93

7.43

1.6

1.7

1755.3

1876.5

0.29

118

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

164

1042

1.59

7.26

1.5

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

451

1.90

7.16

1.2

titre

57.5

154.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

116

677

1.72

7.15

3.6

3.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

376

1.98

7.08

1.7

1.8

—

(3017732) Neutrophils [#/volume] in Blood

529

4162

1.29

7.03

2.8

3.2

e9/l

4.1

0.13

396

3056

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

343

2549

1.36

6.80

2.0

1.8

u/l

38.5

38.7

0.09

297

2185

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.02

6.75

12.8

13.4

mmol/l

4.9

5.2

0.29

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

149

2.56

6.75

1.1

—

(1002224) Polysomnography panel

268

1922

1.41

6.60

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

450

1.85

6.58

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

110

649

1.71

6.56

1.4

1.3

e6/l

208039.5

141154.3

0.33

436

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

189

1271

1.50

6.52

1.1

—

(44790048)

117

703

1.68

6.52

1.6

1.4

—

(44806118)

117

703

1.68

6.52

1.6

1.4

—

(44790047)

117

703

1.68

6.52

1.6

1.4

—

(44790049)

117

703

1.68

6.52

1.6

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

139

873

1.60

6.51

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

180

1199

1.51

6.50

1.2

u/ml

1.4

4.4

—

(3002385) Erythrocyte distribution width [Ratio]

5026

48098

1.15

6.47

27.9

19.6

14.1

13.8

29.03

4941

47003

(3003434) Protein [Mass/volume] in Pleural fluid

159

1033

1.55

6.44

1.6

1.5

g/l

34.1

31.7

1.67

143

927

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

129

798

1.63

6.43

3.4

nmol/l

8.2

14.4

0.41

123

782

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

247

2.15

6.41

1.2

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

146

933

1.58

6.36

3.0

2.5

u/ml

685.0

2233.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

146

934

1.57

6.34

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

464

1.82

6.29

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

274

1995

1.39

6.20

1.4

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

219

1533

1.44

6.19

1.2

u/ml

12.1

42.5

—

(40768806) Pleura Pathology biopsy report

128

799

1.61

6.17

1.7

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

142

910

1.57

6.13

1.5

g/l

0.7

0.8

0.54

107

681

(21494434) Karyotype in Bone marrow

103

612

1.69

6.02

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

158

2.41

6.01

1.1

—

(3012441) Differential panel - Pleural fluid

126

789

1.61

6.01

1.6

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

149

971

1.55

5.99

1.7

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

480

1.78

5.94

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

135

863

1.57

5.91

1.3

1.2

u/ml

296.1

290.7

0.07

530

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1606

14333

1.15

5.84

1.7

pmol/l

41429004.3

29452427.8

0.32

1330

11697

(3021788) Differential panel - Synovial fluid

176

1197

1.48

5.80

1.6

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

521

1.74

5.79

2.3

1.9

u/l

578.4

1641.9

1.00

198

(3048929) Epstein Barr virus Ab [Presence] in Serum

179

1223

1.48

5.76

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

223

1588

1.42

5.76

1.6

—

(3045788) Cell count panel - Pleural fluid

112

690

1.63

5.72

1.6

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

217

1540

1.42

5.72

1.7

1.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

240

1734

1.40

5.71

1.5

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

127

808

1.58

5.69

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

204

1436

1.43

5.63

1.2

1.3

u/ml

8.4

7.2

0.09

243

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

189

1312

1.45

5.62

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

126

803

1.58

5.61

1.5

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

102

619

1.66

5.54

1.1

u/ml

3.3

3.4

0.03

232

(4268621)

523

1.71

5.45

2.2

2.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

136

889

1.54

5.43

1.5

1.3

nmol/l

0.2

0.3

0.66

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

479

1.74

5.43

1.3

1.2

u/ml

2.2

3.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

320

1.91

5.42

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

122

779

1.58

5.40

1.5

1.3

nmol/l

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

112

704

1.60

5.31

1.5

1.3

u/l

293.9

339.1

0.56

106

667

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

221

1596

1.40

5.30

2.3

1.9

mg/l

13.6

11.7

2.60

209

1462

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

350

2711

1.31

5.30

2.8

4.0

u/ml

55.5

64.0

0.20

334

2600

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

507

1.70

5.23

1.2

u/ml

19.6

41.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

118

754

1.57

5.22

3.7

4.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

120

770

1.57

5.22

1.5

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

446

3571

1.27

5.21

3.0

2.9

e6/l

0.4

0.3

0.38

435

3497

(3006922) Hepatitis E virus Ab [Presence] in Serum

350

1.84

5.03

1.1

—

(3006270) Folate [Moles/volume] in Blood

567

1.65

5.00

1.3

1.2

nmol/l

297.5

342.2

1.42

453

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

198

1421

1.40

4.95

1.2

u/ml

1.9

5.2

0.97

154

(3043410) Blood group antigens tested for on Red Blood Cells

168

2.21

4.86

1.9

—

(3038026) Centromere Ab [Units/volume] in Serum

519

1.66

4.83

1.2

u/ml

45.7

63.8

—

(3024263) Appearance of Synovial fluid

363

1.80

4.79

1.4

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

107

683

1.57

4.79

1.4

mmol/l

6.7

6.4

0.63

631

(40762365) Oxygen content in Arterial blood by calculation

125

2.41

4.79

2.3

2.9

ml/dl

14.4

14.9

0.29

117

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

544

1.64

4.76

1.6

u/ml

18.6

24.7

1.34

119

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

183

1306

1.41

4.75

1.6

1.7

iu/l

7.5

4.5

1.01

427

(3035637) Corticotropin [Mass/volume] in Plasma

116

759

1.54

4.67

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.11

4.63

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

112

730

1.54

4.60

1.2

1.1

117.3

115.7

0.18

105

640

(3051593) INR in Capillary blood by Coagulation assay

361

1.78

4.59

10.7

11.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

464

5642

0.81

4.57

5.1

4.0

mmol/l

1.2

0.09

413

4921

(3003181) Sodium [Moles/volume] in Urine

171

1216

1.42

4.54

1.5

1.3

mmol/l

61.8

62.2

0.04

129

987

(3004616) Nuclear Ab [Presence] in Serum

115

758

1.53

4.49

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.86

4.48

1.6

2.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.77

4.44

1.2

nmol/l

5.4

409238.5

0.72

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

145

1005

1.45

4.44

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.82

4.38

1.6

2.2

—

(4306422)

114

755

1.52

4.37

1.2

—

(44813793)

330

1.79

4.37

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

534

1.62

4.36

1.0

1.1

u/ml

1.0

0.09

212

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

203

2.03

4.36

13.4

12.4

mmol/l

0.6

0.52

191

(3051387) C reactive protein [Mass/volume] in Capillary blood

1405

0.64

4.27

4.3

3.7

mg/l

33.0

28.6

0.45

882

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

355

1.75

4.25

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

355

1.75

4.25

1.5

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.70

4.24

5.2

4.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.84

4.21

1.6

umol/l

54.2

40.6

0.70

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

115

770

1.50

4.20

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

159

2.14

4.20

1.9

1.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

200

2.01

4.15

1.1

1.2

—

(4094501)

235

1788

1.32

4.13

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

2.99

4.11

3.2

2.4

umol/l

225.5

597.4

0.62

(3003888) Timothy IgE Ab [Units/volume] in Serum

551

1.59

4.09

1.0

1.1

u/ml

2.4

3.4

0.40

247

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

323

1.77

4.06

1.1

1.0

—

(40768441) Liver Pathology biopsy report

436

1.66

4.05

1.6

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.34

4.03

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

324

1.77

4.03

1.1

1.0

—

(3020491) Glucose [Moles/volume] in Blood

453

1.64

4.00

1.5

2.1

mmol/l

6.8

7.0

0.20

309

(40768446) Kidney Pathology biopsy report

217

1.94

3.99

1.9

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

240

1.88

3.90

2.2

2.1

e6/l

557.9

4036.0

0.54

164

(3021387) Prolactin [Units/volume] in Serum or Plasma

146

1040

1.41

3.90

1.7

mu/l

245.7

314.3

3.85

129

959

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

488

1.60

3.88

1.5

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

214

1624

1.33

3.85

3.4

2.7

mg/l

1.8

1.7

1.02

201

1470

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

329

1.74

3.84

2.2

2.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

397

1.67

3.83

1.8

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

537

1.57

3.82

1.1

1.2

—

(4024509)

657

1.51

3.81

1.8

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

131

920

1.43

3.80

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

406

1.66

3.79

2.3

e6/l

617.7

604.4

0.05

172

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

254

1986

1.29

3.69

1.8

1.7

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

4.00

3.69

1.1

1.2

—

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

639

1.51

3.66

1.1

u/ml

2.1

1.7

0.12

251

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.43

3.61

1.0

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

123

2.20

3.59

1.6

1.8

mg/l

8.5

9.2

0.30

101

(3048879) Bone marrow aspiration report

212

1.89

3.57

1.6

1.7

—

(4062490)

587

1.52

3.55

1.5

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

587

1.52

3.55

1.4

1.3

g/l

2.6

2.9

0.97

412

(3024139) IgG subclass 3 [Mass/volume] in Serum

587

1.52

3.55

1.4

1.3

g/l

0.4

0.02

412

(3027135) IgG subclass 1 [Mass/volume] in Serum

587

1.52

3.55

1.4

1.3

g/l

6.6

6.8

0.30

410

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

160

1179

1.37

3.53

1.5

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

556

1.53

3.53

1.2

1.1

96.1

95.4

0.09

517

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

477

1.58

3.52

1.5

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

105

2.29

3.51

1.1

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

106

728

1.46

3.49

3.6

3.4

60.0

58.3

0.32

455

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

214

1.87

3.48

2.0

1.9

e6/l

2558.1

21825.7

1.32

118

(3002331) Protein [Mass/volume] in Peritoneal fluid

152

2.04

3.45

1.7

1.3

g/l

29.3

27.1

0.36

120

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

152

2.04

3.45

1.1

—

(40761536) Microorganisms panel - Urine sediment

437

5189

0.83

3.43

5.2

4.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.50

3.37

1.3

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

128

917

1.40

3.36

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

328

1.68

3.34

1.9

u/field

4.0

2.1

0.57

224

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

154

2.02

3.34

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

462

1.56

3.28

1.3

titre

68.9

67.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

156

1.99

3.23

1.2

pmol/l

247.9

284.1

0.37

114

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.67

3.22

2.0

umol/l

12.7

18.4

2.00

(3016750) Collection duration of Urine

386

1.61

3.21

2.5

2.1

min

487.4

494.5

0.25

274

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

521

1.52

3.19

1.7

1.6

—

(3049242) von Willebrand panel - Platelet poor plasma

5.34

3.19

1.5

2.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.73

3.15

1.4

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

412

1.58

3.13

1.4

nmol/l

0.3

0.2

0.60

303

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

152

1137

1.34

3.09

1.2

1.3

u/l

33.5

39.0

0.37

137

988

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

245

1.76

3.09

1.9

2.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

129

941

1.38

3.08

1.4

1.2

miu/ml

212.5

203.3

0.09

352

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.68

3.05

1.7

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.00

3.05

1.1

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

479

1.53

3.04

1.3

titre

48.3

304.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

384

1.59

3.04

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

384

1.59

3.04

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

384

1.59

3.04

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.58

3.04

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

119

2.10

3.03

1.7

1.9

e6/l

1302.9

955.1

0.10

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

175

1.89

2.99

1.2

g/l

0.3

0.11

139

(3045142) Bone marrow Pathology biopsy report

110

788

1.40

2.94

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

380

1.58

2.93

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

380

1.58

2.93

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

288

1.67

2.90

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

381

1.58

2.90

1.2

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

177

1.87

2.90

1.5

1.6

g/l

15.3

13.9

0.40

141

(3009466) Valproate [Moles/volume] in Serum or Plasma

111

800

1.39

2.87

5.5

4.7

umol/l

368.2

352.8

0.48

684

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

282

1.67

2.84

1.1

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

126

933

1.36

2.78

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

269

1.68

2.77

9.6

4.5

mg/l

65.6

64.8

0.03

193

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

287

1.64

2.68

1.4

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

200

1589

1.27

2.66

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.79

2.64

1.2

nmol/l

0.3

0.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

162

1255

1.30

2.64

1.4

1.2

mmol/l

3.8

3.9

0.14

151

1163

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.39

2.62

2.2

2.6

u/field

0.3

0.5

0.92

(3025130) Human papilloma virus identified in Specimen

464

1.49

2.61

1.5

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

199

1.76

2.59

1.1

miu/ml

1395.4

1634.2

0.65

199

(3008898) HLA-B27 [Presence]

179

1410

1.28

2.57

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

138

1051

1.32

2.55

1.3

—

(3000330) Specific gravity of Urine by Test strip

399

3419

1.18

2.52

4.2

3.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.27

2.50

1.9

—

(3035880) pH of Pleural fluid

420

1.50

2.50

1.4

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

165

1.82

2.48

1.2

1.3

110.8

112.3

0.09

142

(3004809) Band form neutrophils/100 leukocytes in Blood

153

1188

1.29

2.47

3.4

3.5

1.4

1.5

0.20

115

902

(4146454)

105

773

1.36

2.45

2.4

2.7

—

(3008295) Osmolality of Serum or Plasma

663

1.39

2.44

1.5

1.3

mosm/kgh2o

280.4

278.2

0.34

518

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

264

1.63

2.43

2.0

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

264

1.63

2.43

2.0

2.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

415

1.50

2.42

1.7

1.5

u/l

4.9

6.3

0.32

188

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

189

1.75

2.40

6.7

5.6

64.6

71.7

0.93

153

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1772

16630

1.09

2.40

1.7

mmol/l

1.4

2.43

1547

13710

(3023419) Bacteria identified in Sputum by Culture

116

871

1.34

2.39

2.6

2.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

138

1063

1.30

2.38

1.2

u/ml

47.8

43.2

0.12

116

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

266

1.62

2.37

2.0

2.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

337

1.55

2.36

1.9

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

337

1.55

2.36

1.8

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

337

1.55

2.36

1.8

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

337

1.55

2.36

1.8

2.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

180

1436

1.26

2.36

1.4

1.2

mg/l

506.3

546.6

0.64

164

1354

(3018133) Calcium [Moles/volume] in Urine

2.26

2.34

1.2

1.7

mmol/l

2.6

2.7

0.05

(1761482) Bacteria [#/volume] in Urine by Culture

221

1808

1.23

2.32

4.7

4.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.38

2.29

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

135

1044

1.30

2.27

1.5

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.22

2.27

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

350

1.52

2.23

2.9

2.0

—

(3011288) Drugs identified in Urine by Screen method

481

1.44

2.23

2.9

2.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

263

1.60

2.22

1.6

umol/l

6.5

11.1

0.94

176

(3000034) Microalbumin [Mass/volume] in Urine

641

1.38

2.22

3.5

3.0

mg/l

88.7

51.6

0.27

477

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

367

1.50

2.21

2.1

2.4

e9/l

0.3

0.2

1.56

325

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

217

1.66

2.21

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

100

2.00

2.20

3.6

1.9

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

433

1.46

2.19

1.0

mg/l

276.3

286.5

0.69

386

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

360

1.50

2.18

1.4

1.3

u/ml

3.1

1.1

0.71

178

(3022689) Creatine [Moles/volume] in Urine

180

1.73

2.18

1.3

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

385

1.48

2.17

2.1

2.3

e6/l

625.1

485.8

0.41

325

(3002619) Bacteria identified in Specimen by Culture

115

1.92

2.15

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

220

1.64

2.11

2.0

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

152

1.78

2.11

1.4

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

951

1.30

2.10

1.5

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

1.93

2.10

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

741

6719

1.11

2.07

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.26

2.07

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

357

1.49

2.06

1.5

1.6

u/l

5.2

6.3

1.21

305

(3016018) Differential panel - Cerebral spinal fluid

599

1.37

2.06

1.3

—

(3028433) Virus identified in Specimen by Culture

214

1.64

2.05

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

146

1.78

2.05

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

106

806

1.32

2.05

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

1.74

2.05

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

155

1239

1.26

2.04

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.32

2.04

1.1

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

154

1.76

2.03

1.5

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

217

1.62

1.96

2.6

2.9

umol/l

30.2

29.1

0.26

162

(3020874) Milk IgE Ab [Units/volume] in Serum

179

1.68

1.94

1.2

1.0

u/ml

0.8

0.9

0.07

(3014599) Egg white IgE Ab [Units/volume] in Serum

164

1.71

1.94

1.1

1.0

u/ml

0.7

0.4

0.75

(3022621) pH of Urine by Test strip

476

4224

1.14

1.93

3.5

3.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

369

3218

1.15

1.93

1.2

iu/ml

111.9

135.9

0.57

135

1163

(1616796) Gas panel - Central venous blood

186

1529

1.22

1.92

5.0

3.7

—

(3004775) Volume in Urine collected for unspecified duration

566

1.36

1.89

2.6

2.2

737.1

641.1

1.31

358

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

196

1.64

1.89

1.4

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

149

1200

1.25

1.87

1.8

1.6

nmol/l

1.0

0.8

1.32

123

994

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

220

1.59

1.87

1.4

2.0

u/ml

76682.0

15932.1

—

(3023410) Appearance of Cerebral spinal fluid

533

1.37

1.87

1.5

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.21

1.84

1.0

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

400

1.43

1.83

1.3

1.5

umol/l

14.2

13.8

0.14

376

(3015235) Bicarbonate [Moles/volume] in Capillary blood

213

1784

1.20

1.83

3.5

3.1

mmol/l

24.5

24.9

0.64

183

1549

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

535

1.37

1.83

1.9

2.1

u/field

3.4

1.9

0.53

198

(3016038) Potassium [Moles/volume] in Urine

443

1.40

1.81

1.3

1.1

mmol/l

33.7

35.0

0.15

375

(3013166) Neutrophils/100 leukocytes in Synovial fluid

222

1.58

1.81

1.4

1.3

52.8

55.0

0.11

183

(3001964) Herpes simplex virus Ag [Presence] in Specimen

183

1.64

1.81

1.2

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

295

1.49

1.79

1.5

1.4

52.7

66.6

1.60

237

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

489

1.37

1.74

3.3

5.0

u/ml

20.7

74.2

2.51

142

(3011985) Renin [Units/volume] in Plasma

108

847

1.28

1.72

1.3

1.4

mu/l

88.5

56.7

0.87

753

(3014271) Vancomycin [Susceptibility]

398

1.41

1.70

3.2

3.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.29

1.70

1.0

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

316

1.46

1.68

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.18

1.67

1.0

1.2

u/l

3.6

15.7

1.65

(40758358) Immune stain study

2.80

1.65

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

236

1.53

1.64

1.3

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

269

1.49

1.63

1.2

—

(4015189)

205

1.56

1.61

1.9

2.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

221

1.54

1.61

1.3

ug/l

170.7

379.1

0.52

111

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

151

1243

1.22

1.59

1.4

1.3

e6/l

29.0

27.8

0.02

114

950

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.07

1.59

1.1

1.0

ug/l

97.7

77.3

—

(21494755) Public health laboratory ask at order entry panel

287

3287

0.87

1.59

1.3

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

151

1244

1.22

1.58

1.5

1.4

e6/l

15246.6

1218.9

0.46

117

1005

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

362

1.41

1.58

1.1

nmol/l

1.3

11.7

1.64

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

209

0.48

1.57

1.6

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

183

1.59

1.56

2.4

2.8

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

471

0.66

1.56

4.1

3.4

13.4

13.3

0.30

466

(3023323) Follitropin [Units/volume] in Serum or Plasma

155

1283

1.21

1.56

1.3

1.4

iu/l

34.8

34.7

0.01

128

1099

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

305

1.45

1.55

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.27

1.53

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

298

1.45

1.52

1.5

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

323

1.43

1.52

1.2

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

374

1.39

1.51

2.1

2.2

ug/min

85.8

179.2

0.62

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

162

1.61

1.49

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

194

1.55

1.48

2.0

1.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

292

1.44

1.47

1.1

iu/ml

5.9

10.8

1.22

(3047189) Immunofixation for 24 hour Urine

376

1.39

1.47

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

352

1.39

1.44

1.3

1.1

u/l

89.2

90.1

0.03

272

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

352

1.39

1.44

1.3

1.1

u/l

28.0

32.3

0.14

266

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

100

797

1.26

1.44

1.3

pmol/l

322.7

307.3

0.10

599

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.92

1.43

1.2

ug/l

116.1

126.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.92

1.43

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

499

1.33

1.42

1.0

ng/l

273.4

324.7

0.90

341

(3033705) Calcium.ionized [Moles/volume] in Venous blood

110

889

1.24

1.41

3.0

2.4

—

(4198724)

118

1.70

1.41

2.3

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

142

1.62

1.38

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

502

1.32

1.37

1.0

ng/l

680.7

706.6

0.14

333

(3011648) Oxygen content in Venous blood

512

1.31

1.35

2.1

2.0

10.8

11.1

0.20

512

(3028679) Herpes simplex virus Ab [Presence] in Serum

223

1.48

1.35

1.2

1.1

—

(3034426) Prothrombin time (PT)

183

1.53

1.34

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.14

1.33

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

505

1.31

1.33

1.0

ng/l

34.2

43.6

1.16

340

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.78

1.32

1.2

ng/l

48.2

1012.7

—

(3014051) Protein [Presence] in Urine by Test strip

174

1482

1.18

1.32

2.4

2.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

192

1.51

1.31

1.7

1.4

16.0

23.0

0.83

157

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

463

1.32

1.30

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

226

1.46

1.28

17.5

11.9

nmol/l

838.4

804.3

0.18

210

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

161

1.55

1.28

3.3

2.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

251

1.44

1.28

1.2

1.1

ng/l

649.8

363.8

—

(3044290) Cell count panel - Cerebral spinal fluid

137

1147

1.20

1.28

1.4

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

2.05

1.26

2.1

1.1

nmol/l

5.3

24.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

184

1585

1.16

1.24

2.5

2.2

g/l

124.5

128.1

0.92

108

1138

(3008536) Aspergillus sp Ab [Presence] in Serum

123

1.63

1.23

2.0

1.9

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.63

1.21

1.6

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.80

1.20

1.4

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

180

1552

1.16

1.20

5.8

4.3

kpa

5.1

5.0

0.74

172

1521

(3027315) Oxygen [Partial pressure] in Blood

181

1562

1.16

1.20

5.8

4.3

kpa

8.3

8.5

0.49

173

1530

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

172

1.51

1.20

1.1

1.3

nmol/l

96.3

140.7

1.32

126

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

125

1.60

1.17

1.5

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

748

1.23

1.17

2.2

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

133

1.58

1.17

1.1

1.2

umol/24h

0.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

126

0.48

1.16

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

750

1.23

1.15

2.2

1.7

—

(40768793) Breast Pathology biopsy report

148

1263

1.18

1.14

1.3

1.4

—

(3012501) Base excess in Blood by calculation

179

1551

1.16

1.14

5.8

4.3

mmol/l

3.0

2.6

1.23

126

1074

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.85

1.13

1.2

1.0

iu/ml

6.6

14.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

233

1.42

1.12

26.0

16.6

nmol/l

1481.8

1410.1

0.25

225

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

103

1.65

1.12

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

327

1.35

1.11

1.0

1.1

—

(3010421) pH of Blood

206

1807

1.14

1.11

5.5

4.2

7.4

0.73

171

1522

(4034850)

226

1995

1.14

1.11

12.0

10.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

127

1.58

1.11

1.5

1.6

ng/l

107.7

136.8

0.71

127

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

143

1.54

1.11

1.7

1.9

ug/l

27.0

6.2

0.43

(3028300) Cannabinoids [Presence] in Urine

754

1.22

1.10

2.2

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

251

1.40

1.10

1.1

—

(3042517) Benzodiazepines panel - Urine

2.38

1.09

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

746

1.22

1.09

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

121

1020

1.19

1.09

2.6

2.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.73

1.08

1.1

1.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

193

0.57

1.07

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

193

0.57

1.07

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

192

0.57

1.05

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

192

0.57

1.05

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

489

1.27

1.05

2.0

2.2

36.2

41.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

314

1.34

1.04

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

570

1.25

1.04

1.2

1.1

—

3.5

—

(3016879) Cocaine [Presence] in Urine

697

1.22

1.03

2.2

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

203

0.59

1.03

1.7

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.83

1.02

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.73

1.02

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

122

1.56

1.02

1.4

1.5

14.9

9.2

0.36

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

680

1.22

1.02

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

394

1.30

1.01

1.9

1.6

g/l

0.9

0.89

394

(3010726) Horse dander IgE Ab [Units/volume] in Serum

474

1.27

1.01

1.0

1.1

u/ml

2.8

1.8

0.17

110

(3025315) Body weight

1.89

1.01

5.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

230

1.39

1.01

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

290

1.35

1.01

1.1

1.2

ratio

1.1

0.03

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.00

1.00

2.7

1.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.00

1.00

1.4

1.3

—

(3045716) Anion gap in Serum or Plasma

333

0.69

0.99

4.9

2.2

mmol/l

9.6

9.3

0.12

262

(3023511) Choriogonadotropin [Units/volume] in Urine

231

1.39

0.99

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.17

0.98

1.0

—

(3005033) Fetal Nuchal fold Thickness US

157

0.57

0.98

1.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

240

1.38

0.98

1.7

1.9

ug/l

50.8

52.7

0.09

233

(3047352) Trisomy 18 risk [Likelihood] in Fetus

158

0.57

0.98

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

311

1.32

0.94

1.3

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

225

1.38

0.94

1.2

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.89

0.94

3.7

2.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

669

1.21

0.94

1.2

—

(3027944) Amphetamines [Presence] in Urine

733

1.20

0.93

2.2

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

158

1.46

0.93

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

401

1.27

0.91

1.2

mmol/l

11.3

11.7

0.13

125

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

0.88

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

378

1.27

0.86

1.4

pmol/l

82.5

141.0

0.31

114

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

226

0.66

0.82

2.1

2.0

—

(4281824)

672

1.19

0.81

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

572

1.21

0.80

2.3

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

572

1.21

0.80

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

250

1.32

0.79

1.1

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.82

0.79

4.8

3.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.67

0.78

1.3

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

163

0.61

0.78

1.6

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

260

1.31

0.77

1.4

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

124

1.45

0.75

1.1

1.2

—

555.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

333

1.26

0.74

2.8

3.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1503

15510

0.96

0.71

4.1

3.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.58

0.71

1.0

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

831

1.16

0.71

1.8

1.5

60.2

61.0

0.06

522

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.92

0.70

13.0

8.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

572

1.19

0.70

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

126

1.43

0.70

1.1

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

160

1.38

0.70

1.7

1.6

ug/l

8.2

9.2

0.58

160

(3011412) CD3 cells [#/volume] in Blood

582

1.19

0.69

2.1

2.3

e9/l

1.2

1.1

0.35

360

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

215

2356

0.91

0.69

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

239

1.30

0.68

1.7

2.1

umol/l

85.1

134.5

0.91

134

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

347

1.24

0.67

3.3

2.6

41.6

37.2

—

127

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

168

0.65

0.67

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

249

1.29

0.67

1.9

2.1

umol/l

62.7

57.5

0.32

199

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.63

0.66

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.63

0.66

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

136

1.40

0.66

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.79

0.66

9.8

4.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

188

1.33

0.66

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

111

1.44

0.65

1.6

1.2

mmol/l

0.4

1.9

1.59

(3017181) Myelocytes/100 leukocytes in Blood

577

5477

1.06

0.65

4.1

0.8

1.0

0.97

201

1665

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.57

0.65

1.5

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.61

0.65

2.6

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

624

1.17

0.64

1.2

—

(3019977) pH of Arterial blood

404

1.21

0.64

2.1

2.5

7.4

1.34

146

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

207

1.31

0.63

1.7

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

207

1.31

0.63

1.7

2.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.55

0.62

1.2

1.1

g/l

19.6

16.6

0.70

(3029075) Extractable nuclear Ab panel - Serum

147

1.36

0.61

1.2

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

226

1.28

0.61

1.2

g/l

39.1

39.4

0.03

118

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

113

1.42

0.61

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

253

1.27

0.60

1.1

1.2

—

(3014891) Appearance of Pleural fluid

105

1.43

0.60

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

148

1.35

0.59

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

1.34

0.59

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.51

0.58

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

140

1.36

0.58

1.1

—

(40765096) Chromosome analysis panel by Banding

211

1.28

0.57

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

125

1123

1.12

0.56

1.3

1.5

pmol/l

156.2

205.5

0.51

119

1094

(4133840)

149

0.67

0.56

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

625

1.15

0.55

1.8

1.5

22.6

29.0

0.94

384

(3000012) Reticulocyte production index

395

0.81

0.54

1.7

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

166

1518

1.10

0.54

3.1

2.9

kpa

7.9

0.02

151

1399

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.58

0.54

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.58

0.54

1.8

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

142

1.34

0.54

1.7

1.2

mmol/l

1.7

1.6

0.10

(3015183) Erythrocyte sedimentation rate

186

1.29

0.54

1.5

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.43

0.52

1.2

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.43

0.52

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

443

1.18

0.51

1.4

promille

1.8

1.2

2.05

344

(44806071)

1.41

0.51

1.2

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

135

1.33

0.51

1.2

1.0

u/ml

0.6

0.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

866

1.12

0.50

1.1

iu/ml

142.8

1091.3

0.73

188

(3010838) Calcium [Moles/time] in 24 hour Urine

333

1.20

0.50

1.6

1.8

—

6.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.41

0.50

1.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.46

0.50

3.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

154

1.30

0.48

2.6

2.2

mmol/l

8.0

0.00

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

409

0.83

0.47

1.7

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

164

1.28

0.46

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

407

0.83

0.45

1.7

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

246

1.22

0.45

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

274

1.21

0.44

1.2

1.1

u/l

1.7

1.1

0.41

132

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.40

0.44

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

351

3691

0.95

0.43

1.8

—

(3020650) Glucose [Presence] in Urine

139

1.30

0.43

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

148

1.28

0.43

1.5

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

898

1.10

0.42

2.9

2.2

31.4

32.9

2.26

891

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

138

0.72

0.40

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.31

0.39

7.9

13.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

177

1654

1.07

0.39

1.7

mg/l

6.3

3.6

1.02

135

1202

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

106

1.32

0.39

1.4

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

326

1.17

0.38

1.0

u/ml

0.2

0.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.35

0.37

1.4

1.2

—

(3017569) Oxygen content in Arterial blood

364

1.15

0.37

2.1

—

(3004451) EKG impression Narrative

364

0.85

0.36

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

144

1.25

0.35

1.8

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

124

0.73

0.35

4.2

6.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

126

0.71

0.35

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

442

1.13

0.34

1.9

2.0

14.7

15.4

0.13

172

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

145

0.76

0.34

1.2

1.1

70.6

84.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.34

0.34

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

424

1.13

0.34

1.8

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

481

1.12

0.33

1.3

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.32

0.33

1.3

1.4

mmol/l

8.0

9.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

140

1498

0.93

0.33

1.6

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.32

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

146

1.23

0.32

1.8

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

201

1905

1.06

0.31

1.6

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

571

1.10

0.30

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.33

0.30

1.2

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

438

1.12

0.30

2.6

2.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

439

0.89

0.28

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.27

0.27

1.0

1.3

umol/24h

2.1

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

128

0.78

0.26

1.2

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.21

0.26

4.4

1.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.19

0.26

2.1

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.68

0.26

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

319

0.88

0.25

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

124

1.21

0.23

2.5

3.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.28

0.23

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.28

0.23

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

134

1.19

0.22

1.4

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

313

3030

1.03

0.22

4.8

5.1

1.7

1.6

1.02

296

2835

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.25

0.22

1.0

1.1

—

(3018572) Chloride [Moles/volume] in Blood

157

1644

0.95

0.22

5.7

6.9

mmol/l

105.3

105.0

0.24

139

1470

(3039000) Anion gap in Blood

157

1644

0.95

0.22

5.7

6.9

mmol/l

10.8

11.2

1.10

139

1470

(3040151) Glucose [Moles/volume] in Capillary blood

793

0.93

0.22

5.6

16.0

mmol/l

7.2

7.4

0.14

661

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

296

1.12

0.21

1.5

1.4

g/l

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

309

2996

1.03

0.21

4.9

5.1

0.9

0.37

292

2804

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.16

0.21

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.16

0.21

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.16

0.21

1.0

1.1

—

(3017704) Immunofixation for Urine

402

1.10

0.20

1.4

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

760

1.07

0.20

1.7

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.25

0.20

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.25

0.20

1.3

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

442

1.09

0.19

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.18

0.19

1.2

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

452

1.08

0.19

1.2

mmol/l

2.1

2.2

0.15

422

(21494814) CD8 cells/100 lymphocytes in Specimen

259

0.89

0.18

2.2

2.1

—

(40768795) Lymph node Pathology biopsy report

657

1.07

0.18

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

224

1.12

0.17

1.7

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.18

0.16

1.1

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.18

0.16

1.1

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.18

0.16

1.1

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

567

0.93

0.16

1.5

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.16

0.16

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

120

1.17

0.16

1.1

1.6

—

(3047181) Lactate [Moles/volume] in Blood

217

2236

0.97

0.16

5.1

6.1

mmol/l

1.2

1.3

2.15

188

1981

(4212803)

1.13

0.16

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

380

1.08

0.15

1.0

1.1

u/ml

3.2

2.8

—

146

(3035933) Granulocytes/100 leukocytes in Blood

119

0.84

0.15

1.0

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

529

5198

1.02

0.15

4.2

4.1

0.1

0.2

0.76

173

1550

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

120

1153

1.04

0.15

3.6

3.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.11

0.15

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

169

1.12

0.14

2.1

2.0

219.1

201.3

0.26

157

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

707

6971

1.02

0.14

3.7

3.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

411

1.07

0.14

1.0

1.1

u/ml

1.9

2.5

—

157

(3026470) Cobalt [Mass/volume] in Blood

501

0.94

0.14

1.9

ug/l

5.5

3.4

0.42

439

(3000285) Sodium [Moles/volume] in Blood

103

1.17

0.13

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

314

0.92

0.12

1.6

1.5

1.7

4.1

1.48

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

123

1.14

0.12

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

487

0.94

0.12

2.0

ug/l

2.9

2.2

0.29

403

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

220

1.09

0.11

1.9

188.1

167.6

0.48

205

(3013727) Leukocytes other/100 leukocytes in Blood

240

1.08

0.11

2.5

3.7

58.3

54.2

0.43

231

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

136

0.88

0.11

2.5

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

476

1.05

0.10

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

349

1.06

0.10

1.5

1.3

nmol/l

1.5

1.2

0.79

267

(3021901) Oxygen saturation in Capillary blood

134

1305

1.03

0.09

3.4

2.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

176

0.91

0.09

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

145

0.90

0.09

1.1

1.2

77.1

82.7

—

(3050794) Legionella sp Ab [Presence] in Serum

1.09

0.08

1.2

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.05

0.08

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.03

0.08

1.2

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

369

0.95

0.08

3.4

3.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

292

2963

0.98

0.08

1.3

—

(3001729) Color of Synovial fluid

1.06

0.08

1.7

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.03

0.07

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.80

0.07

1.3

1.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.08

0.07

2.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

147

1.09

0.07

1.6

2.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

353

1.05

0.07

4.6

6.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.12

0.06

1.5

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

113

1152

0.98

0.05

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

658

0.97

0.05

1.1

1.2

mmol/l

6.4

7.7

2.89

478

(3025159) Blasts/100 leukocytes in Blood

490

4863

1.01

0.05

4.2

4.1

0.1

0.3

1.44

154

1302

(40762814) Titanium [Mass/volume] in Blood

130

1.08

0.04

2.4

2.2

ug/l

2.6

3.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

494

4971

0.99

0.04

4.1

3.9

0.6

0.7

0.61

146

1195

(44806420)

221

0.95

0.04

2.1

2.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

170

1.06

0.04

2.3

2.5

nmol/l

102.5

142.9

1.25

147

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

368

1.03

0.04

2.5

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

368

1.03

0.04

1.8

2.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

129

0.93

0.03

1.0

1.3

—

(3012565) Volume of 24 hour Urine

320

1.03

0.03

2.4

2.3

1886.0

1841.6

0.10

273

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

460

0.98

0.02

1.6

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

172

1.05

0.02

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

187

0.96

0.01

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

140

1393

1.01

0.00

1.5

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

125

0.96

0.00

6.1

7.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

179

1.01

0.00

5.8

7.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

106

1.04

0.00

1.0

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

181

0.99

0.00

1.7

1.3

25.9

33.5

—

116

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

102

0.98

0.00

1.1

1.3

108.1

108.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.04

0.00

1.1

1.3

—

(40768800) Prostate Pathology biopsy report

164

1637

1.00

0.00

1.2

—

(4027681)

263

0.99

0.00

1.1

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

162

0.99

0.00

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

162

0.99

0.00

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

162

0.99

0.00

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

162

0.99

0.00

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

126

1.03

0.00

1.5

1.8

ug/l

1.9

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

150

1503

1.00

0.00

3.2

2.6

15.3

16.1

1.57

783

(3038071) Oxygen [Partial pressure] in Mixed venous blood

156

1.03

0.00

6.1

7.9

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.96

0.00

1.0

1.7

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.96

0.00

2.3

1.5

—

(40758292) HTLV I+II Ab panel - Serum

0.93

0.00

1.5

1.4

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.97

0.00

6.2

5.5

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_SIGMOID_COLON and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_SIGMOID_COLON	1.188 [1.09, 1.3]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.24

During the follow-up period (1.1.1998 — 31.12.2019), 3255 out of 15063 females with CD2_BENIGN_SIGMOID_COLON died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_SIGMOID_COLON	1.343 [1.22, 1.48]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 4481 out of 15794 males with CD2_BENIGN_SIGMOID_COLON died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_SIGMOID_COLON.

N-year risk	Females	Males
1	0.126%	0.275%
5	0.637%	1.576%
10	1.702%	3.665%
15	3.241%	7.007%
20	5.867%	12.093%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_SIGMOID_COLON – Benign neoplasm: Sigmoid colon

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Sigmoid colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints